🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, Single-Center, Open-Label study evaluating the safety an...
Status
Completed
Location
Advanced Pharma CR, LLC
Start Date
2025-01-21
Trial ID
NCT06806995
Treatments Being Tested
Study to evaluate the safety and tolerability of multiple escalating doses ...
Status
Completed
Location
Quintiles
Start Date
2016-02
Trial ID
NCT02674347
Treatments Being Tested
Study to evaluate the safety, tolerability and pharmacokinetics of multiple...
Status
Completed
Location
Quintiles
Start Date
2016-03
Trial ID
NCT02707107
Treatments Being Tested
This is a Phase 1, open label, single-dose, pharmacokinetic study to be con...
Status
Completed
Location
University of Miami,Division of Clinical Pharmacology
Start Date
2016-10-25
Trial ID
NCT02942810
Treatments Being Tested
A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled,...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2017-02-09
Trial ID
NCT03554304
Treatments Being Tested
This is a Phase 1, single center study to investigate the safety, tolerabil...
Status
Completed
Location
Altasciences Inc - Kansas City
Start Date
2023-04-19
Trial ID
NCT05645757
Treatments Being Tested
A Phase 1, Open-label Study of the Metabolism and Excretion of Zidebactam (...
Status
Completed
Location
Covance Clinical Research Unit Inc. 3402 Kinsman Boulevard Madison, Wisconsin 53704 USA
Start Date
2017-12-13
Trial ID
NCT07247942
Treatments Being Tested
This is a Phase 3, randomized, double-blind, multicenter, non-inferiority s...
Status
Completed
Location
S&D Clinical Research, LLC
Start Date
2022-08-28
Trial ID
NCT04979806
Treatments Being Tested
This is a Phase 1, multiple dose, open-label pharmacokinetic study in healt...
Status
Completed
Location
Pulmonary Associates
Start Date
2017-03-31
Trial ID
NCT03630094
Treatments Being Tested